Water

Water

SCHEMBL93771

CCCCCCCCCCCCCCCCOC[C@@H](COP(=O)([O-])OCC[N+](C)(C)C)OCCCCC=O.CCCCCCCCCCCCCCCCOC[C@@H](COP(=O)([O-])OCC[N+](C)(C)C)OCCCCC=O.O

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 known ✓ O00255 2/20 0.71
ADRA1D known ✓ P25100 1/20 0.65
HTR1D known ✓ P28221 1/20 0.65
HTR2C known ✓ P28335 1/20 0.65
ADRA1B known ✓ P35368 1/20 0.65
DRD3 known ✓ P35462 1/20 0.65
ESR1 known ✓ P03372 1/20 0.57
ADORA3 known ✓ P0DMS8 1/20 0.57
AGTR1 known ✓ P30556 1/20 0.57
ADRA1A known ✓ P35348 1/20 0.57
ALDH1A1 P00352 2/20 0.71
AKT1 P31749 2/20 0.71
LMNA P02545 2/20 0.71
KMT2A Q03164 2/20 0.71
PRKD3 O94806 1/20 0.71
PRKCG P05129 1/20 0.71
PRKCB P05771 1/20 0.71
PRKCA P17252 1/20 0.71
PRKCH P24723 1/20 0.71
PRKCI P41743 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL94022 0.99 ALDH1A1 (0.73) ALDH1A1AKT1LMNAMEN1KMT2A
SCHEMBL93475 0.99 ALDH1A1 (0.73) ALDH1A1AKT1LMNAMEN1KMT2A
Water SCHEMBL2734485 0.93 AKT1 (0.81) ALDH1A1AKT1LMNAMEN1KMT2A
SCHEMBL29905581 0.92 ALDH1A1 (0.73) ALDH1A1AKT1LMNAMEN1KMT2A
SCHEMBL29394546 0.92 ALDH1A1 (0.73) ALDH1A1AKT1LMNAMEN1KMT2A
SCHEMBL53200 0.92 ALDH1A1 (0.73) ALDH1A1AKT1LMNAMEN1KMT2A
SCHEMBL29365750 0.92 ALDH1A1 (0.73) ALDH1A1AKT1LMNAMEN1KMT2A
SCHEMBL417053 0.92 AKT1 (0.83) ALDH1A1AKT1LMNAMEN1KMT2A
SCHEMBL10602960 0.92 AKT1 (0.83) ALDH1A1AKT1LMNAMEN1KMT2A
SCHEMBL2733343 0.92 AKT1 (0.83) ALDH1A1AKT1LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2425841-A1 Methods Employing and Compositions Containing Defined Oxidized Phospholipids for Prevention and Treatment of Atherosclerosis Vascular Biogenics Ltd. (IL) 2012-03-07 EP disclosed
EP-1341543-A4 METHODS EMPLOYING AND COMPOSITIONS CONTAINING DEFINED OXIDIZED PHOSPHOLIPIDS FOR PREVENTION AND TREATMENT OF ATHEROSCLEROSIS VASCULAR BIOGENICS LTD (IL) 2009-09-02 EP disclosed
EP-1341543-A2 METHODS EMPLOYING AND COMPOSITIONS CONTAINING DEFINED OXIDIZED PHOSPHOLIPIDS FOR PREVENTION AND TREATMENT OF ATHEROSCLEROSIS Vascular Biogenics Ltd. (IL) 2003-09-10 EP disclosed
WO-2002041827-A9 METHODS EMPLOYING AND COMPOSITIONS CONTAINING DEFINED OXIDIZED PHOSPHOLIPIDS FOR PREVENTION AND TREATMENT OF ATHEROSCLEROSIS VASCULAR BIOGENICS LTD (IL) 2003-05-30 WO disclosed
WO-2002041827-A2 METHODS EMPLOYING AND COMPOSITIONS CONTAINING DEFINED OXIDIZED PHOSPHOLIPIDS FOR PREVENTION AND TREATMENT OF ATHEROSCLEROSIS VASCULAR BIOGENICS LTD. (IL) 2002-05-30 WO disclosed